First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers

NCT03482648 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: BBT-401-1S, Single dose
DRUG: BBT-401-1S, Multiple doses
DRUG: Placebo

Sponsor

Bridge Biotherapeutics, Inc.

Collaborators

[object Object]